Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 21, 2016; 22(43): 9586-9594
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9586
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9586
Table 1 Demographic, biological, and histological features for the training and validation groups
Variable | All (n = 193) | Training group (n = 97) | Validation group (n = 96) | P value |
Age, in yr | 39.11 ± 9.31 | 38.70 ± 9.46 | 39.52 ± 9.18 | 0.542 |
Sex, n (%) | 0.601 | |||
Male | 138 (71.5) | 71 (73.2) | 67 (69.8) | |
Female | 55 (28.5) | 26 (26.8) | 29 (30.2) | |
Total bilirubin, in μmol/L | 12.3 (8.7-18.2) | 11.4 (8.6-16.9) | 12.9 (8.8-18.8) | 0.352 |
Albumin, in g/L | 42.21 ± 4.16 | 42.46 ± 3.91 | 41.94 ± 4.41 | 0.387 |
Globulin, in g/L | 27.25 ± 4.36 | 27.54 ± 4.84 | 26.95 ± 3.81 | 0.345 |
ALT, in IU/L | 37 (27-51) | 35 (26.0-48.5) | 38.5 (28-52) | 0.378 |
AST, in IU/L | 30 (25.0-37.5) | 30 (26-38) | 29 (25-37) | 0.806 |
GGT, in IU/L | 27 (18.0-40.5) | 25 (18-38) | 27 (19-43) | 0.577 |
TBA, in mmol/L | 5.9 (3.85-12.05) | 6.5 (4.10-15.25) | 5.45 (3.73-9.83) | 0.146 |
ALP, in IU/L | 69 (57.5-82.5) | 69 (58.0-83.5) | 68.5 (57.0-81.8) | 0.990 |
CHE, in IU/L | 8407.62 ± 2722.19 | 8393.56 ± 2423.51 | 8421.83 ± 3006.82 | 0.943 |
AFP, in ng/mL | 3.25 (2.19-6.32) | 3.30 (2.30-6.70) | 3.20 (2.03-5.08) | 0.377 |
PT, in s | 12.4 (11.9-13.1) | 12.4 (11.95-13.15) | 12.3 (11.80-12.97) | 0.061 |
INR | 1.03 (0.98-1.09) | 1.03 (0.99-1.10) | 1.03 (0.98-1.08) | 0.553 |
HBsAg levels, in log IU/mL | 3.49 (3.12-3.97) | 3.46 (3.08-3.90) | 3.52 (3.16-4.03) | 0.501 |
HBV DNA levels, in logIU/mL | 5.27 ± 1.70 | 5.30 ± 1.67 | 5.24 ± 1.74 | 0.791 |
WBC, in 109/L | 5.63 ± 1.49 | 5.66 ± 1.54 | 5.59 ± 1.44 | 0.723 |
PLT, in 109/L | 179 (144.5-214.5) | 179 (153.5-214.5) | 177 (128.0-214.8) | 0.208 |
CP, in mg/L | 195.67 ± 35.62 | 196.86 ± 35.45 | 196.86 ± 35.45 | 0.643 |
Stage of fibrosis, n (%) | 0.164 | |||
F1 | 76 (39.38) | 42 (43.30) | 34 (35.42) | |
F2 | 44 (22.80) | 23 (23.71) | 21 (21.88) | |
F3 | 42 (21.76) | 18 (18.56) | 24 (25.00) | |
F4 | 31 (16.06) | 14 (14.43) | 17 (17.70) |
- Citation: Zeng DW, Dong J, Jiang JJ, Zhu YY, Liu YR. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase. World J Gastroenterol 2016; 22(43): 9586-9594
- URL: https://www.wjgnet.com/1007-9327/full/v22/i43/9586.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i43.9586